Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Amorfix Life Science

(OTHER OTC: ARFXF)
Add to Portfolio
-0.0034 (-2.18%)
as of Feb 19, 2020

Last 0.1526
Change -0.0034 (-2.18%)
Open 0.1480
Prev. Close 0.1560
Today's Range
0.1480
0.1609
52wk Range
0.1150
0.3356
Volume 136,893
Avg Volume 158,780
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
ARFXF -2.18% +8.15% -30.79%
DJIA +0.40% +6.03% +13.35%
S&P 500 +0.47% +8.62% +21.81%

Key Statistics

Annual EPS -0.0400
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 45,440
Weighted Alpha -35.79
Standard Deviation -0.74
Profit Margin N/A
Beta -0.3800

Growth Rates

YTD +14.74%
1-Year -33.19%
3-Year +20.56%
5-Year +156.58%
10-Year -68.10%

Opinion

Sell Hold Buy

Recent Headlines

ProMIS Neurosciences to Participate in Noble Capital

Globe Newswire via COMTEX - Tue Feb 11, 06:30AM EST
Company to showcase its novel Alzheimer's, Parkinson's and ALS programs(full story)
PMN.TO: 0.21 (+0.01), ARFXF: 0.1526 (-0.0034)

ProMIS Neurosciences to Participate in the BIO CEO &

Globe Newswire via COMTEX - Thu Feb 06, 06:30AM EST
Company to showcase its novel Alzheimer's, Parkinson's and ALS programs(full story)
PMN.TO: 0.21 (+0.01), ARFXF: 0.1526 (-0.0034)

ProMIS Neurosciences Data for Alzheimer's Disease

GlobeNewswire via COMTEX - Wed Jan 29, 06:30AM EST
ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases,(full story)
PMN.TO: 0.21 (+0.01), ARFXF: 0.1526 (-0.0034)

ProMIS Neurosciences Appoints Dr. Jose Luis Molinuevo

GlobeNewswire via COMTEX - Wed Jan 15, 06:30AM EST
ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases,(full story)
PMN.TO: 0.21 (+0.01), ARFXF: 0.1526 (-0.0034)

ProMIS Neurosciences to present at Sachs 3rd Annual

Globe Newswire via COMTEX - Thu Jan 09, 06:30AM EST
Company to showcase its novel Alzheimer's, Parkinson's and ALS programs(full story)
PMN.TO: 0.21 (+0.01), ARFXF: 0.1526 (-0.0034)